EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

N-Acetylcysteine as a Host-Directed Therapy Against Clarithromycin-Resistant Mycobacterium abscessus

Shuqi Yang, Ying Zhang, Jinchuan Xu, Zhenyan Chen, Yang Ren, Yujiao Long, Xuejiao Huang, Juanxi Liu, Huan Huang, Shiqi Xie, Ruiqing Ma, Yajuan Dong und 3 weitere

Pathogens · 2025

DOI: 10.3390/pathogens14040302 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Shuqi Yang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Public Health Clinical Center, Fudan University, 2901 Cao Lang Road, Jinshan District, Shanghai 201508, China. Hauptthemen laut MEDLINE: Acetylcysteine, Mycobacterium abscessus, Clarithromycin, Mycobacterium Infections, Nontuberculous. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Commission of Shanghai Municipality, Shanghai Municipal Science and Technology Major Project, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1)

Background

The treatment of Mycobacterium abscessus (M. abscessus) infections resistant to clarithromycin (CLR) is highly challenging. Traditional non-tuberculous mycobacteria (NTM) chemotherapy may disturb the immune homeostasis of the host by increasing oxidative stress; therefore, host-directed immunotherapy is an alternative option for infections caused by M. abscessus. (2)

Method

A clinical isolate of CLR-resistant M. abscessus was screened, and then the therapeutic effects of N-acetylcysteine (NAC) against CLR-resistant M. abscessus infection were evaluated in Tohoku Hospital Pediatrics-1 (THP-1) cells and murine models. RNA sequencing and Western blot were used to profile the protective immune responses induced by NAC. The contribution of candidate signaling pathways was confirmed by the corresponding inhibitor and agonist. (3)

Results

NAC immunotherapy led to a significant reduction in bacterial loads both in THP-1 cells and murine infection models, which was associated with enhanced antioxidant effects and downregulation of apoptosis signal-regulating kinase 1 (ASK1)–mitogen-activated protein ki-nase/extracellular signal-regulated kinase 3/6 (MKK3/6)–p38 mitogen-activated protein kinase (MAPK)-mediated inflammatory immune responses. The inhibitor of p38 signaling mimicked the protective effect of NAC, while the agonist attenuated it, suggesting that the p38 pathway is crucial in NAC-mediated immune protection against M. abscessus infection. (4)

Conclusion

Our study suggests that NAC could be used as a host-directed therapy agent against drug-resistant M. abscessus infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetylcysteineMycobacterium abscessusClarithromycinMycobacterium Infections, NontuberculousDrug Resistance, BacterialAnti-Bacterial AgentsAnimalsHumansMiceDisease Models, AnimalTHP-1 CellsSignal TransductionFemale

Stichwörter der Autor:innen

Mycobacterium abscessusN-acetylcysteineclarithromycinhost-directed therapyimmune regulationnon-tuberculous mycobacteria

Substanzen

AcetylcysteineClarithromycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Shanghai Public Health Clinical Center, Fudan University, 2901 Cao Lang Road, Jinshan District, Shanghai 201508, China.
  • Tuberculosis Research Center, Shanghai Public Health Clinical Center, 2901 Cao Lang Road, Jinshan District, Shanghai 201508, China.
  • Central Laboratory of Clinical Laboratory Diagnosis, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China.
  • Shanghai Institute of Infectious Diseases and Biosecurity, 138 Medical College Road, Xuhui District, Shanghai 200032, China.

ORCID-Profile: Xiaoyong Fan, Zhidong Hu

Förderung

  • Science and Technology Commission of Shanghai Municipality
  • Shanghai Municipal Science and Technology Major Project
  • National Key Research and Development Program of China

Zitieren

APA

Yang, S., Zhang, Y., Xu, J., Chen, Z., Ren, Y., Long, Y., Huang, X., Liu, J., Huang, H., Xie, S., Ma, R., Dong, Y., Fan, X., Hu, Z., & Li, F. (2025). N-Acetylcysteine as a Host-Directed Therapy Against Clarithromycin-Resistant Mycobacterium abscessus. Pathogens. https://doi.org/10.3390/pathogens14040302

Vancouver

Yang S, Zhang Y, Xu J, Chen Z, Ren Y, Long Y, et al. N-Acetylcysteine as a Host-Directed Therapy Against Clarithromycin-Resistant Mycobacterium abscessus. Pathogens. 2025. doi:10.3390/pathogens14040302

BibTeX
@article{Yang2025,
  author = {Yang, Shuqi and Zhang, Ying and Xu, Jinchuan and Chen, Zhenyan and Ren, Yang and Long, Yujiao and Huang, Xuejiao and Liu, Juanxi and Huang, Huan and Xie, Shiqi and Ma, Ruiqing and Dong, Yajuan and Fan, Xiaoyong and Hu, Zhidong and Li, Feng},
  title = {N-Acetylcysteine as a Host-Directed Therapy Against Clarithromycin-Resistant Mycobacterium abscessus},
  journal = {Pathogens},
  year = {2025},
  doi = {10.3390/pathogens14040302}
}
Kostenlos starten →